Literature DB >> 309370

T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.

R J Rand, D M Jenkins, R Bulmer.   

Abstract

Lymphocyte subpopulations in patients with cervical carcinoma were studied before and after radiotherapy. T lymphocytes were recognized by their ability to form spontaneous rosettes with sheep erythrocytes (E rosettes). Two surface marker characteristics were used to detect B lymphocytes: receptors for activated complement responsible for erythrocyte--antibody--complement (EAC) rosette formation, and surface membrane immunoglobulin (SmIg), readily stainable by immunofluorescence. We have demonstrated a significant depression of total lymphocytes after radiotherapy which persists for more than 5 years. This reduction in lymphocytes is due to a loss of E rosette-forming T cells, SmIg-bearing B cells and null cells. Absolute numbers of EAC rosette-forming B cells are not altered by treatment, and there is a rise in this cell type when the results are expressed as percentages of the total lymphocyte count. The possible functional immunological significance of these changes is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309370      PMCID: PMC1537508     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Active T-rosette-forming cells in the peripheral blood of cancer patients.

Authors:  R H Kerman; R Smith; S S Stefani; E Z Ezdinili
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

2.  Effects of local irradiation (Co60 teletherapy) on the peripheral blood and bone marrow.

Authors:  F A GOSWITZ; G A ANDREWS; R M KNISELEY
Journal:  Blood       Date:  1963-05       Impact factor: 22.113

3.  Effect of radiotherapy on blood lymphocyte population in mammary carcinoma.

Authors:  H Blomgren; R Berg; J Wasserman; U Glas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

4.  Blood lymphocyte subpopulations in breast cancer patients following radiotherapy.

Authors:  B Petrini; J Wasserman; H Blomgren; E Baral
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

5.  Integrated immune response to standard major surgical trauma in normal patients.

Authors:  M S Slade; L J Greenberg; E J Yunis; R L Simmons
Journal:  Surg Forum       Date:  1974

6.  Letter: Lymphocyte response after radiotherapy.

Authors:  S E Wood; J B Campbell; J M Anderson; F Kelly
Journal:  Lancet       Date:  1974-05-04       Impact factor: 79.321

7.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

8.  Blood lymphocytes after radiation therapy of carcinoma of prostate and urinary bladder.

Authors:  H Blomgren; J Wasserman; B Littbrand
Journal:  Acta Radiol Ther Phys Biol       Date:  1974-08

9.  T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.

Authors:  R J Rand; D M Jenkins; R Bulmer
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

10.  Blood lymphocytes after radiation therapy of mammary carcinoma.

Authors:  H Blomgren; U Glas; B Melén; J Wasserman
Journal:  Acta Radiol Ther Phys Biol       Date:  1974-06
View more
  4 in total

1.  Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy.

Authors:  B Petrini; J Wasserman; H Blomgren; E Baral; L E Strender; A Wallgren
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

2.  Mutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy.

Authors:  Saman Shahid; Muhammad Nawaz Chaudhry; Nasir Mahmood
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

3.  Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment.

Authors:  Fiorella D'Auria; Teodora Statuto; Luciana Rago; Antonietta Montagna; Giovanni Castaldo; Irene Schirò; Anna Zeccola; Teresa Virgilio; Gabriella Bianchino; Antonio Traficante; Alessandro Sgambato; Vincenzo Fusco; Luciana Valvano; Giovanni Calice
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

4.  Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.

Authors:  Radhe Mohan; Amy Y Liu; Paul D Brown; Anita Mahajan; Jeffrey Dinh; Caroline Chung; Sarah McAvoy; Mary Frances McAleer; Steven H Lin; Jing Li; Amol J Ghia; Cong Zhu; Erik P Sulman; John F de Groot; Amy B Heimberger; Susan L McGovern; Clemens Grassberger; Helen Shih; Susannah Ellsworth; David R Grosshans
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.